XXVI International Congress of the International Academy of Pathology Montreal, Quebec, Canada Long Course 02 - The Pathology of Prostate Cancer: From Population Studies to the Molecule Monday, September 18, 2006 08:00 - 17:30   Moderators: Dr. John R. Srigley and Dr. Rodolfo Montironi   Disclosure: In accordance with ACCME guidelines regarding disclosure, the USCAP policy requires that faculty members who have a significant financial or other relationship with a commercial company, entity, or service (which will be discussed in this Long Course) must disclose this to attendees. The Academy also requires that speakers disclose any products that are not labeled for the use under discussion. Dr. David Bostwick indicated is owner of Bostwick Laboratories, has grant/research support from GlaxoSmithKline, Genotherapeutics, Dendreon, DiagnoCure and is on scientific advisory board for Endocare. Other faculty members for this Long Course have indicated they have no disclosures to make. Click any blue section number below to display text and references for individual lectures: Section 1 - Introduction John R. Srigley & Rodolfo Montironi Section 2 - Prostate Cancer: Global Scope Of Problem And Epidemiology Theo van der Kwast Section 3 - The Molecular Pathogenesis Of Early Prostate Cancer Angelo De Marzo Section 4 - High-Grade Prostatic Intraepithelial — Neoplasia: 2006 David Bostwick Section 5 - Diagnosis Of Adenocarcinoma In Needle Biopsies Jonathan Epstein Section 6 - Gleason Grading And Other Prognostic Factors In Needle Biopsies Mahul Amin Section 7 - Handling and Reporting Radical Prostatectomy Specimens Lars-Christian Egevad Section 8 - Unusual Carcinomas Of The Prostate Peter Humphrey Section 9 - Prostate Cancer Pathology: Some Futuristic Considerations Mark Rubin